Abstract

Opioid maintenance therapy in pregnant patients can result in children born with neonatal abstinence syndrome (NAS). These infants are at high risk for poor school performance, unemployment, and criminal activity because they never reach the neurocognitive levels of their peers. This article discusses the neurocognitive development consequences of medicated opioid use disorder on infants and children and methods to help them reach their potential into adulthood.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call